We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




3D Network Structures Improve Survival of Transplanted Stem Cell-Derived Neurons

By LabMedica International staff writers
Posted on 27 Mar 2016
Neurological disease researchers have developed a method for treating neurodegenerative diseases such as Parkinson's by transplanting three-dimensional (3D) networks of stem cell-derived neurons into the damaged brain tissue.

Cell replacement therapy using human pluripotent stem cell-derived neurons has the potential to correct neurodegenerative damage and central nervous system injuries, but transplantation of dissociated and spatially disorganized neurons portends poor cell survival and incomplete functional development.

Investigators at Rutgers University (Piscataway, NJ, USA) and Stanford University (Palo Alto, CA, USA) recently described the design of three-dimensional scaffolds based on tunable electrospun microfibrous polymeric substrates. More...
These scaffolds promoted in situ stem cell neuronal reprogramming, neural network establishment, and supported neuronal engraftment into the brain.

The investigators reported in the March 17, 2016, online edition of the journal Nature Communications that they had successfully grafted scaffold-supported, reprogrammed neuronal networks into organotypic hippocampal brain slices. This approach yielded an approximately 3.5-fold improvement in neurite outgrowth and increased action potential firing relative to injected isolated cells. Transplantation of scaffold-supported neuronal networks into mouse brain striatum improved survival by about 38-fold at the injection site relative to injected isolated cells, and allowed delivery of multiple neuronal subtypes.

"If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you are one step closer to getting the brain to communicate with the cells that you are now transplanting," said senior author Dr. Prabhas V. Moghe, professor of biomedical, chemical, and biochemical engineering at Rutgers University. "In this work, we have done that by providing cues for neurons to rapidly network in three dimensions."

Related Links:

Rutgers University
Stanford University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.